The platform will undergo maintenance on Sep 14 at about 7:45 AM EST and will be unavailable for approximately 2 hours.
2018
DOI: 10.1021/acschembio.7b00778
|View full text |Cite
|
Sign up to set email alerts
|

Identifying Novel Enhancer Elements with CRISPR-Based Screens

Abstract: Enhancers control the spatiotemporal expression of genes and are essential for encoding differentiation and development. Since their discovery more than three decades ago, researchers have largely studied enhancers removed from their genomic context. The recent adaptation of CRISPR/Cas9 to genome editing in higher organisms now allows researchers to perturb and test these elements in their genomic context, through both mutation and epigenetic modulation. In this Perspective, we discuss recent advances in scann… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
19
0

Year Published

2018
2018
2023
2023

Publication Types

Select...
6
3

Relationship

2
7

Authors

Journals

citations
Cited by 27 publications
(19 citation statements)
references
References 60 publications
0
19
0
Order By: Relevance
“…For many if not most applications of CRISPR/Cas9-mediated genome engineering, it is used in conjunction with the cell's endogenous NHEJ machinery to introduce short indels in a targeted fashion (Mali et al 2013;Cong et al 2013;Jinek et al 2013) , e.g. to disrupt the function of genes or regulatory elements (Wang et al 2015;Gasperini et al 2017;Klein et al 2018) or to introduce irreversible changes that record cell lineage or molecular events (McKenna et al 2016;Frieda et al 2017;Kalhor et al 2018) . However, despite NHEJ's central importance to this transformative tool, our understanding of the processes that determine the rate and patterns of NHEJ-mediated errors remains incomplete.…”
Section: Introductionmentioning
confidence: 99%
“…For many if not most applications of CRISPR/Cas9-mediated genome engineering, it is used in conjunction with the cell's endogenous NHEJ machinery to introduce short indels in a targeted fashion (Mali et al 2013;Cong et al 2013;Jinek et al 2013) , e.g. to disrupt the function of genes or regulatory elements (Wang et al 2015;Gasperini et al 2017;Klein et al 2018) or to introduce irreversible changes that record cell lineage or molecular events (McKenna et al 2016;Frieda et al 2017;Kalhor et al 2018) . However, despite NHEJ's central importance to this transformative tool, our understanding of the processes that determine the rate and patterns of NHEJ-mediated errors remains incomplete.…”
Section: Introductionmentioning
confidence: 99%
“…Alternative methods of assigning the target genes of regulatory regions, such as those based on correlated chromatin activity of promoters and enhancers (20,(93)(94)(95)(96) may account for the effects of these regions. Emerging high-throughput functional screens of cis-regulatory activity (8,9,64,97) are proving to be instrumental for direct functional validation of enhancer targets identified with either approach.…”
Section: Discussionmentioning
confidence: 99%
“…Unlike RNAi, CRISPR/Cas9-based genome disruption can interrogate not only the function of transcriptionally active regions of the genome but also the non-coding portions, such as enhancers. Several high-throughput strategies have been established to identify possible enhancer regions through CRISPR/Cas9-based genome disruption, many of which use a tiling approach in a cultured cell setting and comprehensively survey a locus of interest with a collection of short guide RNAs (sgRNAs) designed to cover the entirety of the locus (reviewed in Catarino and Stark, 2018;Klein et al, 2018;Lopes et al, 2016). More recently, the next generation of CRISPR/Cas9 technologies, such as CRISPR-based transcriptional activation (CRISPRa) or interference (CRISPRi), have allowed researchers to manipulate the transcription of endogenous loci by taking advantage of the sequence specificity of the CRISPR/Cas9 system (reviewed in Adli, 2018;Pickar-Oliver and Gersbach, 2019).…”
Section: Crispr/cas9-based Screeningmentioning
confidence: 99%